Products like ‘Repatha Inj’ & ‘Soolantra Cream 1%’ enter Asan Medical Center
Amgen’s ‘Repatha Inj’ and Galderma’s ‘Soolantra Cream 1%’ entered Asan Medical Center.
At the 142nd Drug Committee, Asan Medical Center approved introduction of ‘Repatha Inj,’ the Amgen Korea’s PCSK9-inhibiting cholesterol treatment, and ‘Soolantra Cream 1%,’ the Galderma Korea’s local inflammat...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
